Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Serie: | Endocrinology Research and Practice |
| Ämnen: | |
| Länkar: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|